Search Result "immune-related adverse events"
Understanding and Avoiding Antiretroviral Adverse Events
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 9 Year: 2006 Page: 1075-1090
Author(s): Sandra Shibuyama, Anna Gevorkyan, Unsil Yoo, Sophea Tim, Katerina Dzhangiryan, James D. Scott
Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 2 Year: 2017 Page: 210-216
Author(s): Suqing Qu,Weipeng Liu,Hui Yang,Zhaoyan Wang,Yinxiang Yang,Fang Liu,Kan Du,Sheng He,Zuo Luan
Endocrine Adverse Events Related To Immune Checkpoint InhibitorTreatment: Relationship Between Antibodies and Severity of ThyroidDysfunction
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 24 Issue: 14 Year: 2024 Page: 1628-1639
Author(s):
Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 43 Year: 2019 Page: 4570-4578
Author(s): Maoqiang Tian,Jing Yang,Lei Li,Juan Li,Wenting Lei,Xiaomei Shu
Adverse Events of Proton Pump Inhibitors: Potential Mechanisms
Journal: Current Drug Metabolism
Volume: 19 Issue: 2 Year: 2018 Page: 142-154
Author(s): Andrea Corsonello,Fabrizia Lattanzio,Silvia Bustacchini,Sabrina Garasto,Annalisa Cozza,Roberto Schepisi,Federica Lenci,Filippo Luciani,Marcello Giuseppe Maggio,Andrea Ticinesi,Valeria Butto,Sara Tagliaferri,Francesco Corica
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Summarized Overview
Journal: Current Drug Safety
Volume: 14 Issue: 1 Year: 2019 Page: 14-20
Author(s): Kerasia-Maria Plachouri,Eleftheria Vryzaki,Sophia Georgiou
Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Journal: Current Drug Safety
Volume: 6 Issue: 3 Year: 2011 Page: 145-154
Author(s): Roger E. Thomas, Diane L. Lorenzetti, Wendy Spragins, Dave Jackson, Tyler Williamson
Management of Immunotherapy Adverse Events in Oncological Patients: Anti-CTLA-4, Anti-PD-1/PD-L1
Journal: Reviews on Recent Clinical Trials
Volume: 15 Issue: 4 Year: 2020 Page: 339-346
Author(s): Mattia Brigida,Alessia Perricelli,Fausto Sposato,Maria Giovanna Spadafora,Angelo Pomillo,Milito Sisto
A Randomized, Single Centered, Parallel and Open Labelled InterventionalStudy on Effectiveness of Clinical Pharmacists on Adverse Event FollowingImmunization (AEFI) in Pediatric Population
Journal: Current Drug Safety
Volume: 17 Issue: 4 Year: 2022 Page: 357-365
Author(s): Ronit K. Arvind,Faizan A. Beerwala,Shashikala C. Wali,Ashish S. Parihar,Madiwalayya S. Ganachari
The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management
Journal: Current Drug Safety
Volume: 1 Issue: 3 Year: 2006 Page: 271-279
Author(s): A. Magid O. Bakheit